Comparison
Antibodies

EHMT2 Antibody European Partner

Item no. abx001867-50
Manufacturer Abbexa
Amount 50 ul
Type Antibody Primary
Applications WB
Specific against Human, Mouse, Rat
Host Rabbit
Isotype IgG
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Similar products EHMT2
Available
Origin
Human
Description
EHMT2 Antibody is a Rabbit Polyclonal antibody against EHMT2. G9a, also known as Euchromatic histone-lysine N-methyltransferase 2 (EHMT2), is a member of a family of histone lysine methyltransferases, each of which contains a conserved catalytic SET domain originally identified in Drosophila Su[var]3-9, Enhancer of zeste, and Trithorax proteins (1). Recombinant G9a can mono-, di- and tri-methylate histone H3 on Lys9 and Lys27 in vitro (1, 2). However, in vivo G9a forms a complex with GLP, a G9a-related histone methyltransferase, and together these proteins function as the major euchromatic histone H3 Lys9 mono- and di-methyltransferases, creating transcriptionally repressive marks that facilitate gene silencing (3, 4). G9a methylates itself on Lys165, a modification that regulates the association of HP1 repressor proteins with the G9a/GLP complex (5). The G9a/GLP complex also contains Wiz, a zinc finger protein that is required for G9a/GLP hetero-dimerization and complex stability (6). Wiz contains two CtBP co-repressor binding sites, which mediate the association of the G9a/GLP with the CtBP co-repressor complex (6). In addition, G9a and GLP are components of other large transcriptional co-repressor complexes, such as those involving E2F6 and CDP/cut (7-9). G9a interacts with DNMT1, and both proteins are required for methylation of DNA and histone H3 (Lys9) at replication foci, providing a functional link between histone H3 Lys9 and CpG methylation during DNA replication (10). G9a activity is critical for meiotic prophase progression, as mutant mice deficient in germ line G9a show a large loss of mature gametes (11). In addition, G9a facilitates increased global levels of di-methyl histone H3 (Lys9) during hypoxic stress and increased G9a expression is associated with hepatocelluar carcinoma (12, 13). References 1.Tachibana, M. et al. (2001) J Biol Chem 276, 25309-17. 2.Patnaik, D. et al. (2004) J Biol Chem 279, 53248-58. 3.Tachibana, M. et al. (2002) Genes Dev 16, 1779-91. 4.Tachibana, M. et al. (2005) Genes Dev 19, 815-26. 5.Sampath, S.C. et al. (2007) Mol Cell 27, 596-608. 6.Ueda, J. et al. (2006) J Biol Chem 281, 20120-8. 7.Ogawa, H. et al. (2002) Science 296, 1132-6. 8.Shi, Y. et al. (2003) Nature 422, 735-8. 9.Nishio, H. and Walsh, M.J. (2004) Proc Natl Acad Sci USA 101, 11257-62. 10.Esteve, P.O. et al. (2006) Genes Dev 20, 3089-103. 11.Tachibana, M. et al. (2007) EMBO J 26, 3346-59. 12.Kondo, Y. et al. (2007) Hepatol Res 37, 974-83.

Image Legend: Fig. 1. Western blot analysis of extracts of Jurkat cell line, using EHMT2 antibody.
Antigen
EHMT2
Conjugation
Unconjugated
Immunogen
A synthetic peptide of human EHMT2.
Purification
Affinity purified.
Storage
Aliquot and store at -20 C. Avoid repeated freeze/thaw cycles.
Swiss Prot
Q96KQ7
Molecular Weight
132 kDa
Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Lead Time
Shipped within 5-10 working days.
Note
This product is for research use only.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 ul
Available: Out of stock
Questions about this Product?
 
Close